The Vine

On episode #54 of The Vine, PMP talks to Daniel Goldberg, Co-Founder of Palo Santo, an investment fund that is supporting startup psychedelic companies that are purpose-driven and science-informed. Palo Santo's mission is to support promising medical treatments while ensuring access to safe, legal, and effective solutions. 
 
Daniel explains what he and his team look for when vetting new companies and technologies for a potential investment which includes founders who lead with heart, are well intended and have a solid execution plan.
 
The direct and indirect cost of mental health conditions globally was estimated at $2.5 trillion in 2010 and is projected to surge to $6.0 trillion by 2030. Covid has only exacerbated the existing mental health crisis with reported anxiety and depression rates tripling from their pre-Covid levels. 
 
Tune in for a discussion into the promising new mental health treatments on the horizon being funded by Palo Santo.